Scopolamine Patch, Extended Release
Product Images NDC 71335-3015

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Scopolamine (NDC 71335-3015). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713353015)

Scopolamine Transdermal System 1 mg/3 days patch packaging label showing a multipack of 24 transdermal systems. The label includes the Bryant Ranch Prepack logo as the relabeler and LTS Lohmann Therapie-Systeme AG as the manufacturer. Additional details include storage instructions, caution notes, and barcode with NDC 71335-3015-1.*

FDA Label Image

Extended Label (Lbl713353015extendedlabel)

This image shows a dosage and administration instructions panel for Scopolamine transdermal system. It includes steps such as washing and drying hands before application, using only one patch at a time without cutting it, removing the plastic backing, applying the patch behind one ear on a hairless area, and washing hands after application.*

FDA Label Image

Chemical Structure (Scopolamine 01)

Chemical structure of scopolamine, showing its molecular framework including a tropane ring connected to an ester linkage and a phenylpropanoid moiety with hydroxyl and carbonyl functional groups.*

FDA Label Image

Image (Scopolamine 02)

An illustration showing the layered structure of a transdermal patch including the Backing Membrane, Drug Layer, Rate Controlling Membrane, Contact Layer, and Release Liner. The layers are presented in a vertical stack, describing the functional components of the patch.*

FDA Label Image

Figure 1 (Scopolamine 03)

An illustration showing a transdermal Scopolamine patch with labeled parts: a clear disposable release liner, metallic adhesive surface, and tan backing membrane imprinted with 'Scopolamine 1mg/3 days.' The diagram identifies key components of the patch.*

FDA Label Image

Figure 2 (Scopolamine 04)

An instructional diagram labeled as Figure 2 showing a rectangular sheet with a dotted line at the top and an arrow pointing to it labeled 'cut along dotted line.' The sheet contains text lines representing instructions or information, indicating guidance on how to cut along the dotted line on the packaging or insert related to Scopolamine patch.*

FDA Label Image

Figure 3 (Scopolamine 05)

An instructional illustration depicting hands holding a square patch. The image shows the positioning of fingers on the patch, likely demonstrating how to remove or apply the Scopolamine transdermal patch. The patch has a circular element in the center, and the background includes stylized wing-like shapes.*

FDA Label Image

Figure 4 (Scopolamine 06)

An instructional illustration showing the hands peeling a tan-colored Scopolamine transdermal system patch from a clear, disposable release liner, highlighting the metallic adhesive surface of the patch.*

FDA Label Image

Figure 5 (Scopolamine 07)

An instructional illustration showing the correct placement of the Scopolamine extended release patch on the skin behind the ear. The patch is described as a tan-colored transdermal system with an imprint, positioned on the side of the head behind the ear.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.